
"Unlocking Nature's Sweet Potential in Alzheimer's Treatment"
Phyllodulcin, a natural sweetener found in Hydrangea macrophylla var. thunbergii, has shown potential for treating Alzheimer's disease (AD). It inhibits the aggregation of amyloid β (Aβ), a main cause of AD, and decomposes existing Aβ clumps. In an animal model, phyllodulcin reduced memory impairments, decreased Aβ deposition in the hippocampus, and minimized neuroinflammation, key factors in AD. These findings suggest that phyllodulcin could offer a promising new avenue for AD treatment.

